gdc

Web Exclusives

Reduced Efficacy of COVID-19 Vaccination in Immunocompromised Patients
CLL Monthly MinutesLeukemia
COVID-19 vaccination is generally safe for immunocompromised patients, including those with CLL, although the efficacy is substantially lower than in healthy individuals.
Early Results for a Promising New BCL-2 Inhibitor
CLL Monthly MinutesLeukemia
Cell-based assays and animal data suggest that ZN-d5 may be a tolerable and effective treatment for patients with leukemias and lymphomas.
Why It Helps to Share Your Cancer Story and How to Get Started
Sharing your cancer story can promote your sense of what’s truly important, giving you hope and strength in difficult times.
Treating Rare Cancers Can Be Hard: Why Genomic Testing Is Crucial
Genomic TestingCholangiocarcinoma
Jim Palma and John Hopper, Co-Chairs of NORD Rare Cancer Coalition, explain the difference between genetic testing and genomic profile testing, and why all patients with rare cancers should have a genomic profile done to select the best treatment for them based on potential genomic alteration.
Acalabrutinib versus Ibrutinib in Previously Treated CLL
CLL Monthly MinutesLeukemia
The first head-to-head trial of these drugs shows comparable efficacy with a better cardiovascular safety profile for acalabrutinib.
Protecting Patients with CLL from COVID-19
CLL Monthly MinutesLeukemia
A recent study provides some of the first data on COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia.
Promising Data on Zanubrutinib in Previously Treated CLL
CLL Monthly MinutesLeukemia
Preliminary results from the ongoing ALPINE study suggest that zanubrutinib may have superior efficacy and an improved safety profile compared with ibrutinib in previously treated patients with chronic lymphocytic leukemia.
Acalabrutinib Shows Superior Efficacy Over Chemoimmunotherapy
CLL Monthly MinutesLeukemia
Results from the 4-year follow-up of the ELEVATE-TN study support acalabrutinib with or without immunotherapy in previously untreated patients with chronic lymphocytic leukemia.
Maintaining an Intimate Relationship After a Cancer Diagnosis
CLL Monthly MinutesLeukemia
Being diagnosed with cancer and undergoing subsequent treatment can be challenging for patients and their partners, but intimacy does not have to end.
Page 3 of 23
Results 21 - 30 of 221

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country
Gender
Race or Ethnicity
Profession or Role
Primary Interest